0% found this document useful (0 votes)
599 views15 pages

Reports

Patient: Amandio Correia, 64 year old male. Lab results from March 24, 2023 show elevated fasting glucose (7.3 mmol/L) and HbA1c (7.4%), indicating diabetes. Creatinine and eGFR are normal. Lipid levels are normal except HDL cholesterol is low at 1.04 mmol/L. The patient has been referred to Dr. Phillip Segal for follow up on the abnormal diabetes and cholesterol results.

Uploaded by

amandio silva
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
599 views15 pages

Reports

Patient: Amandio Correia, 64 year old male. Lab results from March 24, 2023 show elevated fasting glucose (7.3 mmol/L) and HbA1c (7.4%), indicating diabetes. Creatinine and eGFR are normal. Lipid levels are normal except HDL cholesterol is low at 1.04 mmol/L. The patient has been referred to Dr. Phillip Segal for follow up on the abnormal diabetes and cholesterol results.

Uploaded by

amandio silva
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 15

Patient: DA SILVA, AMANDIO CORREIA Lab No: 2023-1E0836155

Reference #:
Age: 64 years Gender: M Patient ID: 20231E0836155
Date of Birth: Jan 12 1959 Referring Site ID:
Address: 100 International Blvd.
HC #: 6166550316 Toronto, Ontario
Canada M9W 6J6
Patient's Phone: (416) 858-1274 Date of Service: Mar 24 2023 10:00
Telephone: (877) 849-3637
Reported on: Mar 24 2023 23:54 Toll Free: (877) 849-3637
Ordered by: SEGAL DR. PHILLIP Fax: (905) 795-9891
Copy To:
Test Flag Result Reference Range - Units Lab Lic. #
General Comments
#5687
Copy Not Sent Copy To physician was not uniquely identified.

General Chemistry
Glucose Fasting HI 7.3 3.6 - 6.0 mmol/L
Fasting Glucose greater than or equal to 7.0
mmol/L after an 8 hr fast can be used as a
provisional diagnosis of diabetes mellitus. If
asymptomatic, a repeat confirmation test using
Fasting Glucose, HbA1c, or 75g OGTT must be done.
Hemoglobin A1C/Total Hemoglobin HI 7.4 <6.0 %
Diabetes Canada 2018 Guidelines:
--------------------------------------------------
Screening and Diagnosis: < 5.5 % Normal
5.5% - 5.9 % At risk
6.0% - 6.4 % Prediabetes
>OR= 6.5 % Diabetes Mellitus
If HbA1c >OR= 6.5 % and asymptomatic, confirm
using Fasting Glucose, HbA1c or 75g OGTT.
--------------------------------------------------
Monitoring: <OR= 7.0 %
Target in adults without comorbidities. Other
targets may be more appropriate in children,
elderly and patients with comorbidities.
--------------------------------------------------
Results may not accurately reflect mean blood
glucose in patients with hemoglobin variants,
disorders associated with abnormal erythrocyte
turnover, severe renal and liver disorders.
Creatinine 76 67-117 umol/L
Glomerular Filtration Rate (eGFR) 92
Normal eGFR is described as greater than or equal
to 90 ml/min/1.73 m2.

Effective May 4 2015, eGFR is calculated using


the CKD-EPI 2009 equation.

KDIGO 2012 guidelines highlight the importance of


eGFR and urine albumin creatinine ratio (ACR) in
screening, diagnosis and management of CKD.
Results for eGFR should be interpreted in concert
with ACR.

Lab - 5687: LifeLabs, 100 International Blvd., Toronto, Ontario.


Page 1 of 2
FINAL RESULTS
IMPORTANT: This report contains confidential information intended for view by authorized person(s) only and should be
disposed of securely (e.g. shredding) before discarding.
Note to Health Care Providers: This report has been printed by the patient.
Note to patients: Please contact your Health Care Provider if you have any questions regarding the results on this report.
Patient: DA SILVA, AMANDIO CORREIA Lab No: 2023-1E0836155
Reference #:
Age: 64 years Gender: M Patient ID: 20231E0836155
Date of Birth: Jan 12 1959 Referring Site ID:
Address: 100 International Blvd.
HC #: 6166550316 Toronto, Ontario
Canada M9W 6J6
Patient's Phone: (416) 858-1274 Date of Service: Mar 24 2023 10:00
Telephone: (877) 849-3637
Reported on: Mar 24 2023 23:54 Toll Free: (877) 849-3637
Ordered by: SEGAL DR. PHILLIP Fax: (905) 795-9891
Copy To:
Test Flag Result Reference Range - Units Lab Lic. #
Lipids
Hours After Meal Not Available Hours
Triglyceride 1.09 mmol/L
Cholesterol 2.99 mmol/L
HDL Cholesterol 1.04 mmol/L
New formulation (24/Sep/2018): In some patients
with abnormal liver function, the HDL-c result
may be different due to the presence of
lipoproteins with abnormal lipid distribution.
Non HDL Cholesterol 1.95 mmol/L
Non HDL-Cholesterol is not affected by the
fasting status of the patient.
LDL Cholesterol (Calculated) 1.45 mmol/L
LDL-C calculation is decreased if fasting
< or = 10 hours. Consider the Non HDL-C value as
an alternate lipid target if monitoring treatment
in intermediate or high risk patients.
Cholesterol/HDL Cholesterol 2.9
Lipid Target Values Lipid Target Values should be based on patient
10 year CVD risk assessment.

! High or Intermediate CVD risk


-----------!-----------------------------------
Primary ! LDL-C < or = 2.0 mmol/L OR
Tx target ! > or = 50% decrease in LDL-C
!
Alternate ! Non HDL-C < or = 2.6 mmol/L OR
Tx target ! ApoB < or = 0.8 g/L
-----------!-----------------------------------
! Low CVD risk
-----------!-----------------------------------
Primary !> or = 50% decrease in LDL-C
Tx target !
-----------------------------------------------

Random Urine Chemistry


Albumin Creatinine Ratio Urine
Albumin (Urine) 30 mg/L
Creatinine (Urine) 13.9 3.5-24.5 mmol/L
Albumin/Creatinine HI 2.2 < 2.0 mg/mmol

Lab - 5687: LifeLabs, 100 International Blvd., Toronto, Ontario.


Page 2 of 2
FINAL RESULTS
IMPORTANT: This report contains confidential information intended for view by authorized person(s) only and should be
disposed of securely (e.g. shredding) before discarding.
Note to Health Care Providers: This report has been printed by the patient.
Note to patients: Please contact your Health Care Provider if you have any questions regarding the results on this report.
Patient: DA SILVA, AMANDIO Lab No: 2023-1E0384603
Reference #:
Age: 64 years Gender: M Patient ID: 20231E0384603
Date of Birth: Jan 12 1959 Referring Site ID:
Address: 100 International Blvd.
HC #: 6166550316 Toronto, Ontario
Canada M9W 6J6
Patient's Phone: (416) 858-1274 Date of Service: Feb 07 2023 10:20
Telephone: (877) 849-3637
Reported on: Feb 08 2023 00:13 Toll Free: (877) 849-3637
Ordered by: LI DR. IRENE Fax: (905) 795-9891
Copy To: LI DR. IRENE
Test Flag Result Reference Range - Units Lab Lic. #
Hematology
#5687
WBC 9.7 4.0 - 11.0 x E9/L
RBC 4.65 4.50 - 6.00 x E12/L
Hemoglobin LO 107 135 - 175 g/L
Hematocrit LO 0.357 0.400 - 0.500 L/L
MCV LO 77 80 - 100 fL
MCH LO 23.0 27.5 - 33.0 pg
MCHC LO 300 305 - 360 g/L
RDW HI 17.2 11.5 - 14.5 %
Platelet Count 339 150 - 400 x E9/L

Differential
Neutrophils 6.7 2.0 - 7.5 x E9/L
Lymphocytes 1.8 1.0 - 3.5 x E9/L
Monocytes 0.8 0.2 - 1.0 x E9/L
Eosinophils 0.3 0.0 - 0.5 x E9/L
Basophils 0.1 0.0 - 0.2 x E9/L
Immature Granulocytes 0.0 0.0 - 0.1 x E9/L
Nucleated RBC 0 /100 WBC

Biochemical Investigation of Anemias


Ferritin 27 15-275 ug/L

<15 ug/L: diagnostic of iron deficiency


15-30 ug/L: probable iron deficiency
>30 ug/L: iron deficiency unlikely
>100 ug/L: normal iron stores
=>600 ug/L: consider test for iron overload

Effective Oct 24, 2022 this test is performed on


a new analyzer. Results are equivalent and
reference intervals are updated as per clinical
guidelines.

Bone Markers
25-Hydroxy Vitamin D LO 47.2 75.0 - 250.0 nmol/L
Vit D Deficiency: 25.0 - 74.9

Lab - 5687: LifeLabs, 100 International Blvd., Toronto, Ontario.


Page 1 of 1
FINAL RESULTS
IMPORTANT: This report contains confidential information intended for view by authorized person(s) only and should be
disposed of securely (e.g. shredding) before discarding.
Note to Health Care Providers: This report has been printed by the patient.
Note to patients: Please contact your Health Care Provider if you have any questions regarding the results on this report.
Patient: DA SILVA, AMANDIO CORREIA Lab No: 2022-1E9258930
Reference #:
Age: 63 years Gender: M Patient ID: 20221E9258930
Date of Birth: Jan 12 1959 Referring Site ID:
Address: 100 International Blvd.
HC #: 6166550316 Toronto, Ontario
Canada M9W 6J6
Patient's Phone: (416) 858-1274 Date of Service: Nov 21 2022 10:10
Telephone: (877) 849-3637
Reported on: Nov 22 2022 03:08 Toll Free: (877) 849-3637
Ordered by: SEGAL DR. PHILLIP Fax: (905) 795-9891
Copy To: LI DR. IRENE
Test Flag Result Reference Range - Units Lab Lic. #
General Chemistry
#5687
Glucose Random HI 8.8 3.6 - 7.7 mmol/L
Recommend follow-up with Fasting Glucose and/or
HbA1c as per 2013 CDA Guidelines
(Can J Diabetes 2013:37(suppl 1):S1-S212).
Hemoglobin A1C/Total Hemoglobin HI 7.3 <6.0 %
Diabetes Canada 2018 Guidelines:
--------------------------------------------------
Screening and Diagnosis: < 5.5 % Normal
5.5% - 5.9 % At risk
6.0% - 6.4 % Prediabetes
>OR= 6.5 % Diabetes Mellitus
If HbA1c >OR= 6.5 % and asymptomatic, confirm
using Fasting Glucose, HbA1c or 75g OGTT.
--------------------------------------------------
Monitoring: <OR= 7.0 %
Target in adults without comorbidities. Other
targets may be more appropriate in children,
elderly and patients with comorbidities.
--------------------------------------------------
Results may not accurately reflect mean blood
glucose in patients with hemoglobin variants,
disorders associated with abnormal erythrocyte
turnover, severe renal and liver disorders.
Creatinine LO 63 67-117 umol/L
Glomerular Filtration Rate (eGFR) 100
Normal eGFR is described as greater than or equal
to 90 ml/min/1.73 m2.

For patients of African descent, the reported


eGFR must be multiplied by 1.15.

Effective May 4 2015, eGFR is calculated using


the CKD-EPI 2009 equation.

KDIGO 2012 guidelines highlight the importance of


eGFR and urine albumin creatinine ratio (ACR) in
screening, diagnosis and management of CKD.
Results for eGFR should be interpreted in concert
with ACR.

Lab - 5687: LifeLabs, 100 International Blvd., Toronto, Ontario.


Page 1 of 2
FINAL RESULTS
IMPORTANT: This report contains confidential information intended for view by authorized person(s) only and should be
disposed of securely (e.g. shredding) before discarding.
Note to Health Care Providers: This report has been printed by the patient.
Note to patients: Please contact your Health Care Provider if you have any questions regarding the results on this report.
Patient: DA SILVA, AMANDIO CORREIA Lab No: 2022-1E9258930
Reference #:
Age: 63 years Gender: M Patient ID: 20221E9258930
Date of Birth: Jan 12 1959 Referring Site ID:
Address: 100 International Blvd.
HC #: 6166550316 Toronto, Ontario
Canada M9W 6J6
Patient's Phone: (416) 858-1274 Date of Service: Nov 21 2022 10:10
Telephone: (877) 849-3637
Reported on: Nov 22 2022 03:08 Toll Free: (877) 849-3637
Ordered by: SEGAL DR. PHILLIP Fax: (905) 795-9891
Copy To: LI DR. IRENE
Test Flag Result Reference Range - Units Lab Lic. #
Lipids
Hours After Meal Not Available Hours
Triglyceride 0.99 mmol/L
Cholesterol 3.25 mmol/L
HDL Cholesterol 1.04 mmol/L
New formulation (24/Sep/2018): In some patients
with abnormal liver function, the HDL-c result
may be different due to the presence of
lipoproteins with abnormal lipid distribution.
Non HDL Cholesterol 2.21 mmol/L
Non HDL-Cholesterol is not affected by the
fasting status of the patient.
LDL Cholesterol (Calculated) 1.76 mmol/L
LDL-C calculation is decreased if fasting
< or = 10 hours. Consider the Non HDL-C value as
an alternate lipid target if monitoring treatment
in intermediate or high risk patients.
Cholesterol/HDL Cholesterol 3.1
Lipid Target Values Lipid Target Values should be based on patient
10 year CVD risk assessment.

! High or Intermediate CVD risk


-----------!-----------------------------------
Primary ! LDL-C < or = 2.0 mmol/L OR
Tx target ! > or = 50% decrease in LDL-C
!
Alternate ! Non HDL-C < or = 2.6 mmol/L OR
Tx target ! ApoB < or = 0.8 g/L
-----------!-----------------------------------
! Low CVD risk
-----------!-----------------------------------
Primary !> or = 50% decrease in LDL-C
Tx target !
-----------------------------------------------

Random Urine Chemistry


Albumin Creatinine Ratio Urine
Albumin (Urine) 9 mg/L
Creatinine (Urine) 10.6 3.5-24.5 mmol/L
Albumin/Creatinine 0.8 < 2.0 mg/mmol

Lab - 5687: LifeLabs, 100 International Blvd., Toronto, Ontario.


Page 2 of 2
FINAL RESULTS
IMPORTANT: This report contains confidential information intended for view by authorized person(s) only and should be
disposed of securely (e.g. shredding) before discarding.
Note to Health Care Providers: This report has been printed by the patient.
Note to patients: Please contact your Health Care Provider if you have any questions regarding the results on this report.
Patient: DA SILVA, AMANDIO Lab No: 2022-1E8946011
Reference #:
Age: 63 years Gender: M Patient ID: 20221E8946011
Date of Birth: Jan 12 1959 Referring Site ID:
Address: 100 International Blvd.
HC #: 6166550316 Toronto, Ontario
Canada M9W 6J6
Patient's Phone: (416) 858-1274 Date of Service: Oct 21 2022 09:25
Telephone: (877) 849-3637
Reported on: Oct 25 2022 19:47 Toll Free: (877) 849-3637
Ordered by: LI DR. IRENE Fax: (905) 795-9891
Copy To: LI DR. IRENE
Test Flag Result Reference Range - Units Lab Lic. #
Hematology
#5687
WBC 8.8 4.0 - 11.0 x E9/L
RBC LO 4.45 4.50 - 6.00 x E12/L
Hemoglobin LO 99 135 - 175 g/L
Hematocrit LO 0.325 0.400 - 0.500 L/L
MCV LO 73 80 - 100 fL
MCH LO 22.2 27.5 - 33.0 pg
MCHC 305 305 - 360 g/L
RDW HI 18.9 11.5 - 14.5 %
Platelet Count 301 150 - 400 x E9/L

Differential
Neutrophils 5.6 2.0 - 7.5 x E9/L
Lymphocytes 1.9 1.0 - 3.5 x E9/L
Monocytes 0.9 0.2 - 1.0 x E9/L
Eosinophils 0.2 0.0 - 0.5 x E9/L
Basophils 0.2 0.0 - 0.2 x E9/L
Nucleated RBC 0 /100 WBC
Metamyelocytes 0.0 x E9/L
Myelocytes 0.0 x E9/L
Promyelocytes 0.0 x E9/L
Blasts 0.0 x E9/L
Lymphocytes Variant 0.0 x E9/L
Plasma Cells 0.0 x E9/L
Leukocytes Other 0.0 x E9/L

Morphology
WBC Morphology NORMAL
RBC Morphology Slight Hypochromasia
Slight Microcytosis
Platelet Morphology NORMAL
Film held for Pathologist's report.

Pathologist Review --
Features of iron deficiency anemia. Low ferritin
level noted.
A. A. Erfaei M.D., Pathologist

Lab - 5407: KENNEDY, 6560 Kennedy Road, Mississauga, Ontario.


Lab - 5687: LifeLabs, 100 International Blvd., Toronto, Ontario.
Page 1 of 4
FINAL RESULTS
IMPORTANT: This report contains confidential information intended for view by authorized person(s) only and should be
disposed of securely (e.g. shredding) before discarding.
Note to Health Care Providers: This report has been printed by the patient.
Note to patients: Please contact your Health Care Provider if you have any questions regarding the results on this report.
Patient: DA SILVA, AMANDIO Lab No: 2022-1E8946011
Reference #:
Age: 63 years Gender: M Patient ID: 20221E8946011
Date of Birth: Jan 12 1959 Referring Site ID:
Address: 100 International Blvd.
HC #: 6166550316 Toronto, Ontario
Canada M9W 6J6
Patient's Phone: (416) 858-1274 Date of Service: Oct 21 2022 09:25
Telephone: (877) 849-3637
Reported on: Oct 25 2022 19:47 Toll Free: (877) 849-3637
Ordered by: LI DR. IRENE Fax: (905) 795-9891
Copy To: LI DR. IRENE
Test Flag Result Reference Range - Units Lab Lic. #
Biochemical Investigation of Anemias
#5407
Vitamin B12 160 138-652 pmol/L
Ferritin LO 6 22-275 ug/L
Test repeated and results confirmed.

General Chemistry
Glucose Fasting HI 7.1 3.6 - 6.0 mmol/L
Fasting Glucose greater than or equal to 7.0
mmol/L after an 8 hr fast can be used as a
provisional diagnosis of diabetes mellitus. If
asymptomatic, a repeat confirmation test using
Fasting Glucose, HbA1c, or 75g OGTT must be done.

#5687
Hemoglobin A1C/Total Hemoglobin HI 7.3 <6.0 %
Diabetes Canada 2018 Guidelines:
--------------------------------------------------
Screening and Diagnosis: < 5.5 % Normal
5.5% - 5.9 % At risk
6.0% - 6.4 % Prediabetes
>OR= 6.5 % Diabetes Mellitus
If HbA1c >OR= 6.5 % and asymptomatic, confirm
using Fasting Glucose, HbA1c or 75g OGTT.
--------------------------------------------------
Monitoring: <OR= 7.0 %
Target in adults without comorbidities. Other
targets may be more appropriate in children,
elderly and patients with comorbidities.
--------------------------------------------------
Results may not accurately reflect mean blood
glucose in patients with hemoglobin variants,
disorders associated with abnormal erythrocyte
turnover, severe renal and liver disorders.

#5407
Sodium 143 135-145 mmol/L
Potassium 4.7 3.5-5.2 mmol/L
Creatinine 67 67-117 umol/L
Glomerular Filtration Rate (eGFR) 97
Normal eGFR is described as greater than or equal
to 90 ml/min/1.73 m2.

For patients of African descent, the reported


eGFR must be multiplied by 1.15.

Lab - 5407: KENNEDY, 6560 Kennedy Road, Mississauga, Ontario.


Lab - 5687: LifeLabs, 100 International Blvd., Toronto, Ontario.
Page 2 of 4
FINAL RESULTS
IMPORTANT: This report contains confidential information intended for view by authorized person(s) only and should be
disposed of securely (e.g. shredding) before discarding.
Note to Health Care Providers: This report has been printed by the patient.
Note to patients: Please contact your Health Care Provider if you have any questions regarding the results on this report.
Patient: DA SILVA, AMANDIO Lab No: 2022-1E8946011
Reference #:
Age: 63 years Gender: M Patient ID: 20221E8946011
Date of Birth: Jan 12 1959 Referring Site ID:
Address: 100 International Blvd.
HC #: 6166550316 Toronto, Ontario
Canada M9W 6J6
Patient's Phone: (416) 858-1274 Date of Service: Oct 21 2022 09:25
Telephone: (877) 849-3637
Reported on: Oct 25 2022 19:47 Toll Free: (877) 849-3637
Ordered by: LI DR. IRENE Fax: (905) 795-9891
Copy To: LI DR. IRENE
Test Flag Result Reference Range - Units Lab Lic. #
General Chemistry
#5407
Effective May 4 2015, eGFR is calculated using
the CKD-EPI 2009 equation.

KDIGO 2012 guidelines highlight the importance of


eGFR and urine albumin creatinine ratio (ACR) in
screening, diagnosis and management of CKD.
Results for eGFR should be interpreted in concert
with ACR.
Urate 333 230-480 umol/L
Albumin 43 35-52 g/L
Bilirubin Total 8 <20 umol/L
Alkaline Phosphatase 71 40-129 U/L
Alanine Aminotransferase 20 <50 U/L
Aspartate Aminotransferase 12 <35 U/L

Lipids
Hours After Meal Not Available Hours
Triglyceride 0.76 mmol/L
Cholesterol 2.66 mmol/L
HDL Cholesterol 1.18 mmol/L
New formulation (24/Sep/2018): In some patients
with abnormal liver function, the HDL-c result
may be different due to the presence of
lipoproteins with abnormal lipid distribution.
Non HDL Cholesterol 1.48 mmol/L
Non HDL-Cholesterol is not affected by the
fasting status of the patient.
LDL Cholesterol (Calculated) 1.13 mmol/L
LDL-C calculation is decreased if fasting
< or = 10 hours. Consider the Non HDL-C value as
an alternate lipid target if monitoring treatment
in intermediate or high risk patients.
Cholesterol/HDL Cholesterol 2.3
Lipid Target Values Lipid Target Values should be based on patient
10 year CVD risk assessment.

! High or Intermediate CVD risk


-----------!-----------------------------------
Primary ! LDL-C < or = 2.0 mmol/L OR
Tx target ! > or = 50% decrease in LDL-C
!
Alternate ! Non HDL-C < or = 2.6 mmol/L OR
Tx target ! ApoB < or = 0.8 g/L

Lab - 5407: KENNEDY, 6560 Kennedy Road, Mississauga, Ontario.


Lab - 5687: LifeLabs, 100 International Blvd., Toronto, Ontario.
Page 3 of 4
FINAL RESULTS
IMPORTANT: This report contains confidential information intended for view by authorized person(s) only and should be
disposed of securely (e.g. shredding) before discarding.
Note to Health Care Providers: This report has been printed by the patient.
Note to patients: Please contact your Health Care Provider if you have any questions regarding the results on this report.
Patient: DA SILVA, AMANDIO Lab No: 2022-1E8946011
Reference #:
Age: 63 years Gender: M Patient ID: 20221E8946011
Date of Birth: Jan 12 1959 Referring Site ID:
Address: 100 International Blvd.
HC #: 6166550316 Toronto, Ontario
Canada M9W 6J6
Patient's Phone: (416) 858-1274 Date of Service: Oct 21 2022 09:25
Telephone: (877) 849-3637
Reported on: Oct 25 2022 19:47 Toll Free: (877) 849-3637
Ordered by: LI DR. IRENE Fax: (905) 795-9891
Copy To: LI DR. IRENE
Test Flag Result Reference Range - Units Lab Lic. #
Lipids
-----------!-----------------------------------
! Low CVD risk
-----------!-----------------------------------
Primary !> or = 50% decrease in LDL-C
Tx target !
-----------------------------------------------

Random Urine Chemistry


Albumin Creatinine Ratio Urine #5687
Albumin (Urine) 26 mg/L
Creatinine (Urine) 17.8 3.5-24.5 mmol/L
Albumin/Creatinine 1.5 < 2.0 mg/mmol

Thyroid Function
#5407
Thyroid Stimulating Hormone [TSH] 1.04 0.32-4.00 mIU/L

Tumour Markers
#5687
Prostate Specific Antigen 0.33 <4.0 ug/L
Methodology: Abbott Architect immunoassay.
Results should not be interpreted in isolation as
absolute evidence of the presence or absence of
malignant disease.
Changes in serial results may be misleading
unless all Total PSA results are from the same
laboratory method.
Prostate Specific Antigen Free 0.14 ug/L
Prostate Specific Antigen Free/Total Prostate 0.42
Specific Antigen
When Free/Total PSA ratio is <0.11, the
probability of prostate cancer is 44%-56%,
depending on the disease prevalence.
When Free/Total PSA ratio is >0.26 the
probability of prostate cancer is 11%-16%,
depending on the disease prevalence.
The interpretation guidelines above apply only
when the Total PSA is 4.0 to- 10.0 ug/L.

Bone Markers
#5407
25-Hydroxyvitamin D LO 39.4 75.0 - 250.0 nmol/L
Vit D Deficiency: 25.0 - 74.9

New method as of 14 February 2022.

Lab - 5407: KENNEDY, 6560 Kennedy Road, Mississauga, Ontario.


Lab - 5687: LifeLabs, 100 International Blvd., Toronto, Ontario.
Page 4 of 4
FINAL RESULTS
IMPORTANT: This report contains confidential information intended for view by authorized person(s) only and should be
disposed of securely (e.g. shredding) before discarding.
Note to Health Care Providers: This report has been printed by the patient.
Note to patients: Please contact your Health Care Provider if you have any questions regarding the results on this report.
Patient: DA SILVA, AMANDIO Lab No: 2022-108935560
Reference #:
Age: 63 years Gender: M Patient ID: 2022108935560
Date of Birth: Jan 12 1959 Referring Site ID:
Address: 100 International Blvd.
HC #: 6166550316 Toronto, Ontario
Canada M9W 6J6
Patient's Phone: (416) 858-1274 Date of Service: Oct 20 2022 01:43
Telephone: (877) 849-3637
Reported on: Nov 11 2022 08:40 Toll Free: (877) 849-3637
Ordered by: LI DR. IRENE Fax: (905) 795-9891
Copy To: LI DR. IRENE
Test Flag Result Reference Range - Units Lab Lic. #
Fungus Examination
Fungal Culture #5407
Specimen Source NAILS
Collection Date 20-OCT-2022
Collection Time 01:43
Microscopic (KOH Preparation) No fungal elements seen.
Culture Report Fungal Culture
No fungal growth after 3 weeks incubation.

Lab - 5407: KENNEDY, 6560 Kennedy Road, Mississauga, Ontario.


Page 1 of 1
FINAL RESULTS
IMPORTANT: This report contains confidential information intended for view by authorized person(s) only and should be
disposed of securely (e.g. shredding) before discarding.
Note to Health Care Providers: This report has been printed by the patient.
Note to patients: Please contact your Health Care Provider if you have any questions regarding the results on this report.
Patient: DA SILVA, AMANDIO Lab No: 2022-1E8212274
Reference #:
Age: 63 years Gender: M Patient ID: 20221E8212274
Date of Birth: Jan 12 1959 Referring Site ID:
Address: 100 International Blvd.
HC #: 6166550316 Toronto, Ontario
Canada M9W 6J6
Patient's Phone: (416) 858-1274 Date of Service: Aug 09 2022 10:45
Telephone: (877) 849-3637
Reported on: Aug 10 2022 06:01 Toll Free: (877) 849-3637
Ordered by: LI DR. IRENE Fax: (905) 795-9891
Copy To: LI DR. IRENE
Test Flag Result Reference Range - Units Lab Lic. #
Hematology
#5687
WBC 9.9 4.0 - 11.0 x E9/L
RBC 4.76 4.50 - 6.00 x E12/L
Hemoglobin LO 97 135 - 175 g/L
Hematocrit LO 0.335 0.400 - 0.500 L/L
MCV LO 70 80 - 100 fL
MCH LO 20.4 27.5 - 33.0 pg
MCHC LO 290 305 - 360 g/L
RDW HI 20.2 11.5 - 14.5 %
Platelet Count 322 150 - 400 x E9/L

Differential
Neutrophils 6.8 2.0 - 7.5 x E9/L
Lymphocytes 1.7 1.0 - 3.5 x E9/L
Monocytes 0.9 0.2 - 1.0 x E9/L
Eosinophils 0.3 0.0 - 0.5 x E9/L
Basophils 0.1 0.0 - 0.2 x E9/L
Immature Granulocytes 0.0 0.0 - 0.1 x E9/L
Nucleated RBC 0 /100 WBC

Morphology
WBC Morphology NORMAL
RBC Morphology Few Elliptocytes/Ovalocytes
Slight Hypochromasia
Slight Microcytosis
Dual Population
Platelet Morphology NORMAL

Coagulation Studies
INR 1.1 0.9 - 1.2
Prothrombin Time
International Normalized Ratio Therapeutic Range
------------------------------------------------
Prophylaxis and treatment of
Thromboembolism 2.0 - 3.0

Patient with mechanical


prosthetic heart valve 2.5 - 3.5

Lab - 5687: LifeLabs, 100 International Blvd., Toronto, Ontario.


Page 1 of 1
FINAL RESULTS
IMPORTANT: This report contains confidential information intended for view by authorized person(s) only and should be
disposed of securely (e.g. shredding) before discarding.
Note to Health Care Providers: This report has been printed by the patient.
Note to patients: Please contact your Health Care Provider if you have any questions regarding the results on this report.
Patient: DA SILVA, AMANDIO Lab No: 2022-1E7953164
Reference #:
Age: 63 years Gender: M Patient ID: 20221E7953164
Date of Birth: Jan 12 1959 Referring Site ID:
Address: 100 International Blvd.
HC #: 6166550316 Toronto, Ontario
Canada M9W 6J6
Patient's Phone: (416) 858-1274 Date of Service: Jul 14 2022 09:45
Telephone: (877) 849-3637
Reported on: Jul 14 2022 22:06 Toll Free: (877) 849-3637
Ordered by: SWALLOW DR. CAROL Fax: (905) 795-9891
Copy To: LI DR. IRENE
Test Flag Result Reference Range - Units Lab Lic. #
General Chemistry
#5687
Creatinine 76 67-117 umol/L
Glomerular Filtration Rate (eGFR) 92
Normal eGFR is described as greater than or equal
to 90 ml/min/1.73 m2.

For patients of African descent, the reported


eGFR must be multiplied by 1.15.

Effective May 4 2015, eGFR is calculated using


the CKD-EPI 2009 equation.

KDIGO 2012 guidelines highlight the importance of


eGFR and urine albumin creatinine ratio (ACR) in
screening, diagnosis and management of CKD.
Results for eGFR should be interpreted in concert
with ACR.

Lab - 5687: LifeLabs, 100 International Blvd., Toronto, Ontario.


Page 1 of 1
FINAL RESULTS
IMPORTANT: This report contains confidential information intended for view by authorized person(s) only and should be
disposed of securely (e.g. shredding) before discarding.
Note to Health Care Providers: This report has been printed by the patient.
Note to patients: Please contact your Health Care Provider if you have any questions regarding the results on this report.
Patient: DA SILVA, AMANDIO Lab No: 2022-107323568
Reference #:
Age: 63 years Gender: M Patient ID: 2022107323568
Date of Birth: Jan 12 1959 Referring Site ID:
Address: 100 International Blvd.
HC #: 6166550316 Toronto, Ontario
Canada M9W 6J6
Patient's Phone: (416) 858-1274 Date of Service: May 12 2022 11:47
Telephone: (877) 849-3637
Reported on: May 16 2022 17:09 Toll Free: (877) 849-3637
Ordered by: LI DR. IRENE Fax: (905) 795-9891
Copy To: LI DR. IRENE
Test Flag Result Reference Range - Units Lab Lic. #
Hematology
#5687
WBC 10.7 4.0 - 11.0 x E9/L
RBC LO 3.76 4.50 - 6.00 x E12/L
Hemoglobin LO 85 135 - 175 g/L
Hematocrit LO 0.280 0.400 - 0.500 L/L
MCV LO 75 80 - 100 fL
MCH LO 22.6 27.5 - 33.0 pg
MCHC LO 304 305 - 360 g/L
RDW HI 18.4 11.5 - 14.5 %
Platelet Count HI 413 150 - 400 x E9/L

Differential
Neutrophils HI 7.9 2.0 - 7.5 x E9/L
Lymphocytes 1.4 1.0 - 3.5 x E9/L
Monocytes 1.0 0.2 - 1.0 x E9/L
Eosinophils 0.2 0.0 - 0.5 x E9/L
Basophils 0.1 0.0 - 0.2 x E9/L
Immature Granulocytes 0.0 0.0 - 0.1 x E9/L
Nucleated RBC 0 /100 WBC

Morphology
WBC Morphology Neutrophilia
RBC Morphology Slight Hypochromasia
Slight Microcytosis
Slightly increased Polychromasia
Dual Population
Platelet Morphology Increased slightly
Film held for Pathologist's report.

Pathologist Review --
Rule out iron deficiency anemia and chronic blood
loss. Consider serum ferritin and investigation
for blood loss. Neutrophilia - rule out
infection or inflammation. Thrombocytosis may be
reactive. Consider infection/inflammation or
hemorrhage.
A. A. Erfaei M.D., Pathologist

Lab - 5687: LifeLabs, 100 International Blvd., Toronto, Ontario.


Page 1 of 2
FINAL RESULTS
IMPORTANT: This report contains confidential information intended for view by authorized person(s) only and should be
disposed of securely (e.g. shredding) before discarding.
Note to Health Care Providers: This report has been printed by the patient.
Note to patients: Please contact your Health Care Provider if you have any questions regarding the results on this report.
Patient: DA SILVA, AMANDIO Lab No: 2022-107323568
Reference #:
Age: 63 years Gender: M Patient ID: 2022107323568
Date of Birth: Jan 12 1959 Referring Site ID:
Address: 100 International Blvd.
HC #: 6166550316 Toronto, Ontario
Canada M9W 6J6
Patient's Phone: (416) 858-1274 Date of Service: May 12 2022 11:47
Telephone: (877) 849-3637
Reported on: May 16 2022 17:09 Toll Free: (877) 849-3637
Ordered by: LI DR. IRENE Fax: (905) 795-9891
Copy To: LI DR. IRENE
Test Flag Result Reference Range - Units Lab Lic. #
Coagulation Studies
INR 1.4 0.9 - 1.2
Prothrombin Time
International Normalized Ratio Therapeutic Range
------------------------------------------------
Prophylaxis and treatment of
Thromboembolism 2.0 - 3.0

Patient with mechanical


prosthetic heart valve 2.5 - 3.5

Biochemical Investigation of Anemias


Ferritin LO 6 22-275 ug/L
Test repeated and results confirmed.

Lab - 5687: LifeLabs, 100 International Blvd., Toronto, Ontario.


Page 2 of 2
FINAL RESULTS
IMPORTANT: This report contains confidential information intended for view by authorized person(s) only and should be
disposed of securely (e.g. shredding) before discarding.
Note to Health Care Providers: This report has been printed by the patient.
Note to patients: Please contact your Health Care Provider if you have any questions regarding the results on this report.
Patient: DA SILVA, AMANDIO Lab No: 2022-106843644
Reference #:
Age: 63 years Gender: M Patient ID: 2022106843644
Date of Birth: Jan 12 1959 Referring Site ID:
Address: 100 International Blvd.
HC #: 6166550316 Toronto, Ontario
Canada M9W 6J6
Patient's Phone: (416) 858-1274 Date of Service: Mar 25 2022 10:15
Telephone: (877) 849-3637
Reported on: Mar 25 2022 21:15 Toll Free: (877) 849-3637
Ordered by: LI DR. IRENE Fax: (905) 795-9891
Copy To: LI DR. IRENE
Test Flag Result Reference Range - Units Lab Lic. #
Coagulation Studies
#5687
INR 3.3 0.9 - 1.2
Prothrombin Time
International Normalized Ratio Therapeutic Range
------------------------------------------------
Prophylaxis and treatment of
Thromboembolism 2.0 - 3.0

Patient with mechanical


prosthetic heart valve 2.5 - 3.5

Lab - 5687: LifeLabs, 100 International Blvd., Toronto, Ontario.


Page 1 of 1
FINAL RESULTS
IMPORTANT: This report contains confidential information intended for view by authorized person(s) only and should be
disposed of securely (e.g. shredding) before discarding.
Note to Health Care Providers: This report has been printed by the patient.
Note to patients: Please contact your Health Care Provider if you have any questions regarding the results on this report.

You might also like

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy